FDA approves new drug Qbrexza for Hyperhidrosis (Excessive Sweating)
The FDA has recently approved Qbrexza (glycopyrronium), a once-daily topical treatment, for primary axillary hyperhidrosis (excessive underarm sweating). Healthline interviewed various dermatologists about this in a recent article. Excessive sweating affects nearly 10 million people in the United States, occurring similarly in both men and women.
“This isn’t just a cosmetic condition. I’ve had patients that don’t want to go to their kids’ graduation because they are worried that they are going to sweat so much that they are going to sweat through their clothing or they can’t shake people’s hands because they are dripping,” said Dr. Michele S. Green, a board-certified dermatologist.
There are also cosmetic treatment methods that can work for hyperhidrosis. For example, the use of Botox to treat excessive sweating is also common, but requires injections intermittently.
“Botox works, but it’s not 100 percent and we have to redo it every three to six months, depending on how much you are sweating. So, that’s not ideal for some patients because it’s expensive and they have to come back,” said Green.
Read the full article at https://www.healthline.com/health-news/excessive-sweating-new-drug